Astemizole-based anticancer therapy for hepatocellular carcinoma (HCC), and Eag1 channels as potential early-stage markers of HCC

Article

Abstract: Hepatocellular carcinoma (HCC) has very poor prognosis. Astemizole has gained great interest as a po

Palabras claves:

Astemizole, Eag1, Liver cancer, Liver cirrhosis, Potassium channels, tumor markers

Autores:

Acuña-Macías I., Caro-Sánchez C.H., Chiliquinga A.J., de Guadalupe Chávez-López M., Díaz-Chávez J., Gariglio P., Hernández-gallegos E., Herrera L.A., Javier Camacho, Pérez-Carreón J.I., Zúñiga-García V.

Fuentes:

scopus